Evidence map›Paper›PMID 34460006›Full record

SynthesisWiener klinische Wochenschrift2021

Role of new digital technologies and telemedicine in pulmonary rehabilitation : Smart devices in the treatment of chronic respiratory diseases.

Monika Fekete, Vince Fazekas-Pongor, Peter Balazs, Stefano Tarantini, Anna N Nemeth, Janos Tamas Varga

Open access · hybridAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Wiener klinische Wochenschrift, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Review
  11. [Cost-effectiveness of digital care and face-to-face care in the first-level of care].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Lung Transplant Rehabilitation-A Review.Life (Basel, Switzerland) · 2023
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Monika FeketeDepartment of Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.ORCID http://orcid.org/0000-0001-8632-2120
Vince Fazekas-PongorDepartment of Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Peter BalazsDepartment of Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Stefano TarantiniDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Anna N NemethDepartment of Public Health, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Janos Tamas VargaDepartment of Pulmonology, Semmelweis University, Budapest, Hungary. varga.janos_tamas@med.semmelweis-univ.hu.ORCID https://orcid.org/0000-0002-8552-1336
Semmelweis University · HUUniversity of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma and chronic obstructive pulmonary diseases are conditions characterized by a variable progression. Some individuals experience longer asymptomatic periods while others acute worsening periods and/or exacerbations triggered by symptom multiplication factors. Medications are adjusted to the patients' respiratory function, self-assessment of health and emerging certain physical changes. A more effective treatment may be applied by real-time data registered during the patient's everyday life. AIM AND

methodsIntroducing new modern digital technology in pulmonary rehabilitation (PR) to help tracking the patients' medication, thus we systematically reviewed the latest publications on telemedicine and pulmonary telerehabilitation.

conclusionThe use of the latest digital technologies in PR is very exciting and offers great opportunities while treating patients affected by specific conditions. On the one hand, adherence to medication can be improved in patients with chronic respiratory diseases by using these new state of the art devices; on the other hand, digital devices will also be able to monitor various physiological parameters of patients during their usual everyday activities. Data can be stored on a smartphone and shared with the provider. Relying on this information, physicians will be able to tailor medications and dosage to the specific needs of individual patients. Telerehabilitation may be a sustainable solution to the growing burden of chronic respiratory disease worldwide. However, PR must keep its cornerstones, such as education and motivations, which are most successful when conducted in person. Many issues remain to be resolved in the future, e.g. cybersecurity while using smart devices since they offer unique opportunities for PR.

Indexed as

Pulmonary Disease, Chronic ObstructiveTelemedicineTelerehabilitationDigital TechnologyHumansSmartphoneHigh-technologyPulmonary rehabilitationRespiratory diseasesSmart devicesTelemedicina

Identifiers

PMID34460006
PMCPMC8599213
OpenAlexW3196520068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.